Cytek Biosciences Q4 EPS $(0.34) Misses $(0.02) Estimate, Sales $62.141M Beat $57.187M Estimate
Benzinga Newsdesk 8 months ago
EarningsEarnings BeatsEarnings MissesNews
Cytek Biosciences (NASDAQ:CTKB) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.02) by 1378.26 percent. This is a 585.71 percent decrease over earnings of $0.07 per share
Cytek Biosciences (NASDAQ:CTKB) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.02) by 1378.26 percent. This is a 585.71 percent decrease over earnings of $0.07 per share from the same period last year. The company reported quarterly sales of $62.141 million which beat the analyst consensus estimate of $57.187 million by 8.66 percent. This is a 8.12 percent increase over sales of $57.476 million the same period last year.